According to the Zhitong Finance APP, INKON Life (300143.SZ) released its 2024 annual report, showing an operating income of 1.559 billion yuan, a year-on-year increase of 6.01%. The net profit attributable to shareholders of the listed company was 115 million yuan, a year-on-year increase of 14.92%. The net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 83.3721 million yuan, a year-on-year decrease of 19.46%. The basic earnings per share were 0.18 yuan.

During the reporting period, the company's medical services generated revenue of 1.192 billion yuan, a year-on-year increase of 3.76%; outpatient visits reached 496,658, a year-on-year increase of 4%, and inpatient admissions reached 48,355, a year-on-year increase of 6%, reflecting the hospital's upgraded ability to attract patients; during the reporting period, tumor revenue increased by 17%, demonstrating the results of the tumor ecosystem evolution; the volume of tertiary and quaternary surgeries continued to increase by 2% year-on-year on a high base, reflecting the high quality of the hospital's technical level in various disciplines